CARB-X is Funding Baltimore’s Novel Microdevices to Develop a Rapid and Portable Diagnostic for STDs Including Antibiotic-Resistant Infections

Published on :

CARB-X is funding Novel Microdevices to develop a rapid and portable diagnostic for sexually transmitted diseases including antibiotic-resistant infections  New portable battery-powered diagnostic is designed to be easy-to-use in any setting around [….]

Baltimore’s BondTrue Awarded Competitive Grant from the National Science Foundation

Published on :

Baltimore’s BondTrue Awarded Competitive Grant from the National Science Foundation Small Business Innovation Research Program Provides Seed Funding for R&D BALTIMORE, Md., March 30, 2021 – BondTrue, LLC (BondTrue) has been awarded [….]

Baltimore’s Longeviti Launches ClearFit Covers, Allowing Post-Operative Ultrasound Imaging for Brain Surgery Patients

Published on :

Baltimore’s Longeviti Launches ClearFit Covers, Allowing Post-Operative Ultrasound Imaging for Brain Surgery Patients BALTIMORE–(BUSINESS WIRE)–Longeviti Neuro Solutions, a medtech company developing innovative solutions for complex brain surgery, today announced the [….]

Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center

Published on :

Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center Manufacturing Innovative Diagnostic Products for Enhancing Patient Healthcare BALTIMORE (PRWEB) FEBRUARY 26, 2021 The LaunchPort™ announced today that Novel Microdevices (http://www.noveldx.com) has moved [….]

Baltimore’s Personal Genome Diagnostics and Fox Chase Cancer Center Announce Partnership to Broaden Liquid Biopsy Applications in Oncology Clinical Research

Published on :

Personal Genome Diagnostics and Fox Chase Cancer Center Announce Partnership to Broaden Liquid Biopsy Applications in Oncology Clinical Research BALTIMORE, Md.–(BUSINESS WIRE)–Personal Genome Diagnostics Inc. (PGDx), a leader in cancer [….]

5 Questions with Ken Malone, Co-Founder, and Principal, Early Charm Ventures, LLC.

Published on :

Ken Malone is a co-founder of Early Charm Ventures, a venture studio founded in 2012 in Baltimore (Charm City) that converts science to business. Early Charm specializes in taking brilliant scientific discoveries made at universities and turning them into companies focused on growth. They don’t chase quick exits. They build companies that create sustainable value.